Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
WuXi PharmaTech (药明康德) was named one of the Top...
Sinovac Biotech (北京科兴生物制品有限公司)...
LEAD Therapeutics has released data on LT-29, a novel...
Charles River Laboratories reported that its year-old...
The California Institute for Regenerative Medicine (CIRM)...
Boehringer Ingelheim will invest $149 million in China...
China Sky One Medical (中国天字一号医药公司)...
Medicilon/MPI Preclinical Research-Shanghai has received...
Sinopharm Group could win the $3 billion auction for...
Scientists from aTyr Pharma published research in Nature...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
